Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Thoracic Surgery

  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 185 articles:
HTML format

Single Articles

    September 2021
  1. NANNA MG, Wang TY, Chiswell K, Sun JL, et al
    Estimating the real-world performance of the PROMISE minimal-risk tool.
    Am Heart J. 2021;239:100-109.
    PubMed     Abstract available

  2. DESAI MY, Wolski K, Owens A, Naidu SS, et al
    Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy.
    Am Heart J. 2021;239:80-89.
    PubMed     Abstract available

  3. BARBERY CE, Giczewska A, White J, Lokhnygina Y, et al
    Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus.
    Am Heart J. 2021;239:59-63.
    PubMed     Abstract available

    June 2021
  4. HU X, Wang Y
    Importance of complete revascularization and surgical techniques when comparing outcomes of CABG with PCI.
    Am Heart J. 2021;236:107-108.

  5. VAIYANI D, Matsuo K, Kanaan U, Patel B, et al
    Total vascular resistance increases during volume-unloading in asymptomatic single ventricle patients.
    Am Heart J. 2021;236:69-79.
    PubMed     Abstract available

    May 2021
  6. BAJAJ R, Parasa R, Ramasamy A, Makariou N, et al
    Computerized technologies informing cardiac catheterization and guiding coronary intervention.
    Am Heart J. 2021 May 30. pii: S0002-8703(21)00146.
    PubMed     Abstract available

  7. MYLES PS, Richards T, Klein A, Smith J, et al
    Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery (ITACS) trial.
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00137.
    PubMed     Abstract available

  8. GRUBB CS, Truby LK, Topkara VK, Bohnen MS, et al
    Advanced Heart Failure Patients Supported with Ambulatory Inotropic Therapy: What Defines Success of Therapy?
    Am Heart J. 2021 May 10. pii: S0002-8703(21)00121.
    PubMed     Abstract available

  9. YERASI C, Case BC, Chezar-Azerrad C, Forrestal BJ, et al
    Cangrelor vs. Glycoprotein IIb/IIIa Inhibitors During Percutaneous Coronary Intervention.
    Am Heart J. 2021 May 4. pii: S0002-8703(21)00115.
    PubMed     Abstract available

  10. JOSHI A, Mancini R, Probst S, Abikhzer G, et al
    Sarcopenia in Cardiac Surgery: Dual X-Ray Absorptiometry Study from the McGill Frailty Registry.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00110.
    PubMed     Abstract available

  11. SIDEBOTTOM AC, Miedema MD, Benson G, Vacquier M, et al
    The Impact of a Population-based Prevention Program on Cardiovascular Events: Findings from the Heart of New Ulm Project.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00112.
    PubMed     Abstract available

    March 2021
  12. KIVINIEMI T, Bustamante-Munguira J, Olsson C, Jeppsson A, et al
    A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol.
    Am Heart J. 2021 Mar 30. pii: S0002-8703(21)00087.
    PubMed     Abstract available

  13. LOWENSTERN A, Sheridan P, Wang TY, Boero I, et al
    Sex Disparities in Patients with Symptomatic Severe Aortic Stenosis.
    Am Heart J. 2021 Mar 12. pii: S0002-8703(21)00074.
    PubMed     Abstract available

  14. WAKSMAN R, Torguson R, Medranda GA, Shea C, et al
    Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Results from the LRT Trial.
    Am Heart J. 2021 Mar 10. pii: S0002-8703(21)00071.
    PubMed     Abstract available

  15. QU J, Du J, Rao C, Chen S, et al
    Effect of a Smartphone-Based Intervention on Secondary Prevention Medication Prescriptions After Coronary Artery Bypass Graft Surgery: The MISSION-1 Randomized Controlled Trial.
    Am Heart J. 2021 Mar 6. pii: S0002-8703(21)00070.
    PubMed     Abstract available

    February 2021
  16. BATCHELOR WB, Damluji AA, Yong C, Fiuzat M, et al
    Am Heart J. 2021 Feb 23. pii: S0002-8703(21)00035.
    PubMed     Abstract available

  17. INSAF TZ, Sommerhalter KM, Jaff TA, Farr SL, et al
    Access to cardiac surgery centers for cardiac and non-cardiac hospitalizations in adolescents and adults with congenital heart defects- a descriptive case series study.
    Am Heart J. 2021 Feb 23. pii: S0002-8703(21)00058.
    PubMed     Abstract available

  18. RO O, Qr Y, A E, P A, et al
    Cardiac transplantation outcomes in patients with amyloid cardiomyopathy.
    Am Heart J. 2021 Feb 20. pii: S0002-8703(21)00055.
    PubMed     Abstract available

  19. PILGRIM T, Rothenbuhler M, Siontis GC, Kandzari DE, et al
    Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of individual patient data from five randomized trials.
    Am Heart J. 2021 Feb 17. pii: S0002-8703(21)00048.
    PubMed     Abstract available

  20. PRABHU KM, Don C, Sayre GG, Kearney KE, et al
    Interventional Cardiologists' Perceptions of Percutaneous Coronary Intervention Quality Measurement and Feedback.
    Am Heart J. 2021 Feb 7. pii: S0002-8703(21)00032.
    PubMed     Abstract available

  21. BROPHY TJ, Warsavage TJ, Hebbe AL, Plomondon ME, et al
    Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction: Insights from the VA CART Program.
    Am Heart J. 2021 Feb 7. pii: S0002-8703(21)00034.
    PubMed     Abstract available

    January 2021
  22. SAWANO M, Spertus JA, Masoudi FA, Rumsfeld JS, et al
    Bleeding Avoidance Strategies and Percutaneous Coronary Intervention Outcomes: A Ten-year Observation from a Japanese Multicenter Registry: Post-PCI Bleeding Avoidance and Outcomes.
    Am Heart J. 2021 Jan 17. pii: S0002-8703(21)00014.
    PubMed     Abstract available

  23. GE Z, Kan J, Gao XF, Kong XQ, et al
    Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: rationale and design of a prospective, randomized and multicenter DKCRUSH VIII trial.
    Am Heart J. 2021 Jan 16. pii: S0002-8703(21)00015.
    PubMed     Abstract available

  24. ADACHI Y, Yamamoto M, Shimura T, Yamaguchi R, et al
    Late kidney injury after transcatheter aortic valve replacement.
    Am Heart J. 2021 Jan 14. pii: S0002-8703(21)00011.
    PubMed     Abstract available

  25. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available

  26. THIELE H, Freund A, Gimenez MR, de Waha-Thiele S, et al
    Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial.
    Am Heart J. 2021 Jan 8. pii: S0002-8703(21)00004.
    PubMed     Abstract available

  27. YERASI C, Tripathi B, Wang Y, Forrestal BJ, et al
    National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: An analysis from the Nationwide Readmissions Database, 2012-2016.
    Am Heart J. 2021;231:25-31.
    PubMed     Abstract available

    December 2020
  28. MENTIAS A, Sarrazin MV, Desai M, Kapadia S, et al
    Expansion of Transcatheter Aortic Valve Replacement in the United States: Expansion of TAVR in US.
    Am Heart J. 2020 Dec 31. pii: S0002-8703(20)30427.
    PubMed     Abstract available

  29. MALIK AO, Amin A, Kennedy K, Qintar M, et al
    Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention.
    Am Heart J. 2020 Dec 23. pii: S0002-8703(20)30415.
    PubMed     Abstract available

  30. NUCCIA M, Claudia M, Alice S, Guido T, et al
    Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: rationale and design of the randomized Altshock- 2 trial.
    Am Heart J. 2020 Dec 15. pii: S0002-8703(20)30399.
    PubMed     Abstract available

  31. CHOUDHARY R, Kumari V
    Aspirin versus P2Y12 inhibitor-based monotherapy after percutaneous coronary intervention.
    Am Heart J. 2020;230:99.

  32. JOYCE J, O'Leary ET, Mah DY, Harrild DM, et al
    Cardiac resynchronization therapy improves the ventricular function of patients with Fontan physiology.
    Am Heart J. 2020;230:82-92.
    PubMed     Abstract available

    November 2020
  33. KAWASHIMA H, Soliman O, Wang R, Ono M, et al
    Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial.
    Am Heart J. 2020 Nov 5. pii: S0002-8703(20)30368.
    PubMed     Abstract available

  34. DAYAN V, Myers P
    Comparing apples and oranges and adding inches to meters: Is this the way to conduct rigorous meta-analyses of PCI versus CABG in left main coronary disease?
    Am Heart J. 2020;229:180-181.

  35. KUNO T, Ueyama H, Rao SV, Cohen MG, et al
    Meta-analysis of PCI vs. CABG for left main disease revisited.
    Am Heart J. 2020;229:178-179.

    October 2020
  36. JAWITZ OK, Stebbins AS, Raman V, Alhanti B, et al
    Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial.
    Am Heart J. 2020 Oct 27. pii: S0002-8703(20)30352.
    PubMed     Abstract available

  37. NOWAK RM, Jacobsen G, Jr AL, Peacock WF, et al
    Outpatient versus Observation/Inpatient Management of Emergency Department Patients Rapidly Ruled-out for Acute Myocardial Infarction: Findings from the HIGH-US Study.
    Am Heart J. 2020 Oct 27. pii: S0002-8703(20)30353.
    PubMed     Abstract available

  38. NATHAN AS, Yang L, Geng Z, Dayoub EJ, et al
    Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.
    Am Heart J. 2020;232:1-9.
    PubMed     Abstract available

  39. JAWITZ OK, Cox ML, Ranney D, Williams JB, et al
    Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial.
    Am Heart J. 2020;228:91-97.
    PubMed     Abstract available

    September 2020
  40. SHAIKH A, Ochani RK, Khan MS, Riaz H, et al
    Contribution of individual components to composite endpoints in contemporary cardiovascular randomized controlled trials.
    Am Heart J. 2020 Sep 14. pii: S0002-8703(20)30254.
    PubMed     Abstract available

    August 2020
  41. BISCAGLIA S, Guiducci V, Santarelli A, Santos IA, et al
    Physiology-guided revascularization versus optimal medical therapy of non-culprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial.
    Am Heart J. 2020 Aug 18. pii: S0002-8703(20)30237.
    PubMed     Abstract available

  42. KANG DY, Ahn JM, Park H, Lee PH, et al
    Comparison of optical coherence tomography-guided versus intravascular ultrasound-guided percutaneous coronary intervention: Rationale and design of a randomized, controlled OCTIVUS trial.
    Am Heart J. 2020;228:72-80.
    PubMed     Abstract available

  43. CHENG Y, Xue FS, Liu SH
    Does central venous pressure really affect the risk of diuretic-associated acute kidney injury after cardiac surgery?
    Am Heart J. 2020;226:253-254.

  44. MCCOY I, Montez-Rath M, Chertow G, Chang T, et al
    Does really central venous pressure affect the risk of diuretic-associated acute kidney injury after cardiac surgery?
    Am Heart J. 2020;226:252.

  45. KATZ JN
    Back to the future-Are we ready for a randomized trial of surgical versus percutaneous revascularization in cardiogenic shock?
    Am Heart J. 2020;226:264-266.

    July 2020
  46. BHARDWAJ B, Cohen DJ, Vemulapalli S, Kosinski AS, et al
    Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry.
    Am Heart J. 2020;228:57-64.
    PubMed     Abstract available

  47. PLOUMEN EH, Buiten RA, Doggen CJM, Stoel MG, et al
    New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
    Am Heart J. 2020;228:109-115.
    PubMed     Abstract available

  48. YU C, Liu C, Du J, Liu H, et al
    Smartphone-based application to improve medication adherence in patients after surgical coronary revascularization.
    Am Heart J. 2020;228:17-26.
    PubMed     Abstract available

    June 2020
  49. ELTCHANINOFF H, Bonaros N, Prendergast B, Nietlispach F, et al
    Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve interventio
    Am Heart J. 2020;228:27-35.
    PubMed     Abstract available

  50. YAN Y, Wang X, Guo J, Li Y, et al
    Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial i
    Am Heart J. 2020;227:19-30.
    PubMed     Abstract available

  51. KUNO T, Ueyama H, Takagi H, Bangalore S, et al
    P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials.
    Am Heart J. 2020;227:82-90.
    PubMed     Abstract available

  52. KUNO T, Ueyama H, Rao SV, Cohen MG, et al
    Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials.
    Am Heart J. 2020;227:9-10.
    PubMed     Abstract available

  53. LAMBERT LM, McCrindle BW, Pemberton VL, Hollenbeck-Pringle D, et al
    Longitudinal study of anthropometry in Fontan survivors: Pediatric Heart Network Fontan study.
    Am Heart J. 2020;224:192-200.
    PubMed     Abstract available

  54. HOLMES DR JR, Mack MJ, Alkhouli M, Vemulapalli S, et al
    Racial disparities and democratization of health care: A focus on TAVR in the United States.
    Am Heart J. 2020;224:166-170.

  55. ERHUN F, Kaplan RS, Narayanan VG, Brayton K, et al
    Are cost advantages from a modern Indian hospital transferable to the United States?
    Am Heart J. 2020;224:148-155.
    PubMed     Abstract available

  56. ROSS FJ, Radman M, Jacobs ML, Sassano-Miguel C, et al
    Associations between anthropometric indices and outcomes of congenital heart operations in infants and young children: An analysis of data from the Society of Thoracic Surgeons Database.
    Am Heart J. 2020;224:85-97.
    PubMed     Abstract available

    May 2020
  57. SMILOWITZ NR, Galloway AC, Ohman EM, Rao SV, et al
    Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey.
    Am Heart J. 2020;225:55-59.
    PubMed     Abstract available

    April 2020
  58. GUEDENEY P, Thiele H, Kerneis M, Barthelemy O, et al
    Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial.
    Am Heart J. 2020;225:60-68.
    PubMed     Abstract available

  59. LAINE M, Lemesle G, Burtey S, Cayla G, et al
    TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial.
    Am Heart J. 2020;225:19-26.
    PubMed     Abstract available

  60. LUDWIG S, Gossling A, Waldschmidt L, Linder M, et al
    TAVR for low-flow, low-gradient aortic stenosis: Prognostic impact of aortic valve calcification.
    Am Heart J. 2020;225:138-148.
    PubMed     Abstract available

  61. DAMLUJI AA, Rodriguez G, Noel T, Davis L, et al
    Sarcopenia and health-related quality of life in older adults after transcatheter aortic valve replacement.
    Am Heart J. 2020;224:171-181.
    PubMed     Abstract available

  62. DANDEL M, Hetzer R
    Impact of rejection-related immune responses on the initiation and progression of cardiac allograft vasculopathy.
    Am Heart J. 2020;222:46-63.

    March 2020
  63. YOON YH, Ahn JM, Kang DY, Park H, et al
    Pragmatic trial comparing routine versus no routine functional testing in high-risk patients who underwent percutaneous coronary intervention: Rationale and design of POST-PCI trial.
    Am Heart J. 2020;224:156-165.
    PubMed     Abstract available

  64. OSMAN M, Saleem M, Osman K, Kheiri B, et al
    Radial versus femoral access for percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: Trial sequential analysis.
    Am Heart J. 2020;224:98-104.
    PubMed     Abstract available

  65. RAGNARSSON S, Janiec M, Modrau IS, Dreifaldt M, et al
    No-touch saphenous vein grafts in coronary artery surgery (SWEDEGRAFT): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial.
    Am Heart J. 2020;224:17-24.
    PubMed     Abstract available

  66. SMILOWITZ NR, Alviar CL, Katz SD, Hochman JS, et al
    Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock.
    Am Heart J. 2020 Mar 12. pii: S0002-8703(20)30080.
    PubMed     Abstract available

  67. VLACHOJANNIS GJ, Vogel RF, Wilschut JM, Lemmert ME, et al
    COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial.
    Am Heart J. 2020;224:10-16.
    PubMed     Abstract available

    Consequences of impressive myectomy results in a Center of Excellence: The paradox of evidence-based medicine era.
    Am Heart J. 2020;221:157-158.

  69. GESKE JB, Driver CN, Yogeswaran V, Ommen SR, et al
    Comparison of expected and observed outcomes for septal myectomy in hypertrophic obstructive cardiomyopathy.
    Am Heart J. 2020;221:159-164.
    PubMed     Abstract available

    February 2020
  70. SONG L, Tu S, Sun Z, Wang Y, et al
    Quantitative flow ratio-guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial.
    Am Heart J. 2020;223:72-80.
    PubMed     Abstract available

  71. JAWITZ OK, Gulack BC, Brennan JM, Thibault DP, et al
    Association of postoperative complications and outcomes following coronary artery bypass grafting.
    Am Heart J. 2020;222:220-228.
    PubMed     Abstract available

  72. PINEDA AM, Rymer J, Wang A, Banks AZ, et al
    Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis.
    Am Heart J. 2020;224:105-112.
    PubMed     Abstract available

  73. ROZENBAUM Z, Finkelstein A, Zhitomirsky S, Topilsky Y, et al
    Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Am Heart J. 2020;220:184-191.
    PubMed     Abstract available

    January 2020
  74. KALBACHER D, Tigges E, Boekstegers P, Puls M, et al
    Underweight is associated with inferior short and long-term outcomes after MitraClip implantation: Results from the German TRAnscatheter mitral valve interventions (TRAMI) registry.
    Am Heart J. 2020;222:73-82.
    PubMed     Abstract available

  75. ARASHI H, Sato T, Kobashigawa J, Luikart H, et al
    Long-term clinical outcomes with use of an angiotensin-converting enzyme inhibitor early after heart transplantation.
    Am Heart J. 2020;222:30-37.
    PubMed     Abstract available

  76. KINNAIRD T, Gallagher S, Spratt JC, Ludman P, et al
    Complex high-risk and indicated percutaneous coronary intervention for stable angina: Does operator volume influence patient outcome?
    Am Heart J. 2020;222:15-25.
    PubMed     Abstract available

  77. NANNA MG, Peterson ED, Wu A, Harding T, et al
    Age, knowledge, preferences, and risk tolerance for invasive cardiac care.
    Am Heart J. 2020;219:99-108.
    PubMed     Abstract available

    December 2019
  78. MCCOY IE, Montez-Rath ME, Chertow GM, Chang TI, et al
    Central venous pressure and the risk of diuretic-associated acute kidney injury in patients after cardiac surgery.
    Am Heart J. 2019;221:67-73.
    PubMed     Abstract available

  79. SHLOFMITZ E, Torguson R, Zhang C, Craig PE, et al
    Impact of Intravascular Ultrasound on Outcomes Following PErcutaneous Coronary InterventioN in Complex Lesions (iOPEN Complex).
    Am Heart J. 2019;221:74-83.
    PubMed     Abstract available

  80. WILLEMSEN LM, Janssen PWA, Hackeng CM, Kelder JC, et al
    A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Am Heart J. 2019;220:237-245.
    PubMed     Abstract available

  81. HILL KD, Baldwin HS, Bichel DP, Butts RJ, et al
    Rationale and design of the STeroids to REduce Systemic inflammation after infant heart Surgery (STRESS) trial.
    Am Heart J. 2019;220:192-202.
    PubMed     Abstract available

  82. FREITAS-FERRAZ AB, Rodes-Cabau J, Junquera Vega L, Beaudoin J, et al
    Transesophageal echocardiography complications associated with interventional cardiology procedures.
    Am Heart J. 2019;221:19-28.
    PubMed     Abstract available

  83. PATEL DM, Thiessen-Philbrook H, Brown JR, McArthur E, et al
    Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery.
    Am Heart J. 2019;220:253-263.
    PubMed     Abstract available

  84. MEGALY M, Gossl M, Sorajja P, Anzia LE, et al
    Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement.
    Am Heart J. 2019;218:128-132.
    PubMed     Abstract available

  85. EGBE AC, Najam M, Banala K, Vojjini R, et al
    Impact of atrial arrhythmia on survival in adults with tetralogy of Fallot.
    Am Heart J. 2019;218:1-7.
    PubMed     Abstract available

    October 2019
  86. SHI J, Zhou C, Liu S, Sun H, et al
    Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial.
    Am Heart J. 2019;222:147-156.
    PubMed     Abstract available

  87. RYMER JA, Mandawat A, Abbott JD, Cohen MG, et al
    Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial.
    Am Heart J. 2019;218:84-91.
    PubMed     Abstract available

  88. OHUCHI H, Negishi J, Hayama Y, Miike H, et al
    Abnormal glucose metabolism in patients with Fontan circulation: Unique characteristics and associations with Fontan pathophysiology.
    Am Heart J. 2019;216:125-135.
    PubMed     Abstract available

    September 2019
  89. BRENNAN JM, Wruck L, Pencina MJ, Clare RM, et al
    Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials.
    Am Heart J. 2019;218:110-122.
    PubMed     Abstract available

  90. LOWENSTERN A, Wu J, Bradley SM, Fanaroff AC, et al
    Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry.
    Am Heart J. 2019;215:167-177.
    PubMed     Abstract available

    August 2019
  91. PARK S, Ahn JM, Lee K, Kwon O, et al
    Long-term (10-year) outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease.
    Am Heart J. 2019;218:9-19.
    PubMed     Abstract available

    July 2019
  92. SMILOWITZ NR, Lorin J, Berger JS
    Risks of noncardiac surgery early after percutaneous coronary intervention.
    Am Heart J. 2019;217:64-71.
    PubMed     Abstract available

  93. MAURI L, Doros G, Rao SV, Cohen DJ, et al
    The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale.
    Am Heart J. 2019;216:82-90.
    PubMed     Abstract available

  94. FARIDI KF, Rymer JA, Rao SV, Dai D, et al
    Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry.
    Am Heart J. 2019;216:53-61.
    PubMed     Abstract available

  95. ADAMO M, Grasso C, Capodanno D, Rubbio AP, et al
    Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: Insights from the multicenter GRASP-IT registry.
    Am Heart J. 2019;217:32-41.
    PubMed     Abstract available

  96. PINA LM, Dong X, Zhang L, Samtani MN, et al
    Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study).
    Am Heart J. 2019;213:97-104.
    PubMed     Abstract available

    June 2019
  97. MEHTA SR, Wood DA, Meeks B, Storey RF, et al
    Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation
    Am Heart J. 2019;215:157-166.
    PubMed     Abstract available

  98. LENG W, Yang J, Fan X, Sun Y, et al
    Contemporary invasive management and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry.
    Am Heart J. 2019;215:1-11.
    PubMed     Abstract available

  99. BAMFORD P, Lau GT
    One database, 2 studies, and a trebling of atherectomy rates.
    Am Heart J. 2019;212:157.

  100. STROM JB, Tamez H, Zhao Y, Valsdottir LR, et al
    Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.
    Am Heart J. 2019;212:64-71.
    PubMed     Abstract available

    May 2019
  101. TOTH G, Brodmann M, Barbato E, Mangiacapra F, et al
    Rational and design of the INtentional COronary revascularization versus conservative therapy in patients undergOing successful peripheRAl arTEry revascularization due to critical limb ischemia trial (INCORPORATE trial).
    Am Heart J. 2019;214:107-112.
    PubMed     Abstract available

  102. ALEXANDRE J, Ollitrault P, Fischer MO, Fellahi JL, et al
    Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial.
    Am Heart J. 2019;214:88-96.
    PubMed     Abstract available

  103. GELMAN A, Carlin JB, Nallamothu BK
    Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) and coronary stents: A case study in the analysis and reporting of clinical trials.
    Am Heart J. 2019;214:54-59.

  104. DOUCET S, Jolicoeur EM, Serruys PW, Ragosta M 3rd, et al
    Outcomes of left main revascularization in patients with acute coronary syndromes and stable ischemic heart disease: Analysis from the EXCEL trial.
    Am Heart J. 2019;214:9-17.
    PubMed     Abstract available

  105. LAKKIREDDY D, Windecker S, Thaler D, Sondergaard L, et al
    Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial).
    Am Heart J. 2019;211:45-53.
    PubMed     Abstract available

    April 2019
  106. ZIMMERMANN FM, De Bruyne B, Pijls NHJ, Desai M, et al
    A protocol update of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 trial: A comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with
    Am Heart J. 2019;214:156-157.

  107. QINTAR M, Hirai T, Arnold SV, Sheehy J, et al
    De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status.
    Am Heart J. 2019;214:1-8.
    PubMed     Abstract available

  108. INOHARA T, Shrader P, Pieper K, Blanco RG, et al
    Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.
    Am Heart J. 2019;213:81-90.
    PubMed     Abstract available

  109. SULLIVAN LT 2ND, Mulder H, Chiswell K, Shaw LK, et al
    Racial differences in long-term outcomes among black and white patients with drug-eluting stents.
    Am Heart J. 2019;214:46-53.
    PubMed     Abstract available

  110. VAN ZANDVOORT LJC, Masdjedi K, Tovar Forero MN, Lenzen MJ, et al
    Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care: Rationale and study design of the prospective randomized FFR-REACT trial.
    Am Heart J. 2019;213:66-72.
    PubMed     Abstract available

  111. HSU S
    Response to the letter to the editor regarding the results of the retrospective study "Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock" published in the American Heart Journal.
    Am Heart J. 2019 Apr 6. pii: S0002-8703(19)30067.

    March 2019
  112. SACCO A, Morici N, Oliva F
    Letter to the editor regarding the results of the retrospective study "Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock" published in the American Heart Journal.
    Am Heart J. 2019 Mar 23. pii: S0002-8703(19)30056.

  113. BING R, Everett RJ, Tuck C, Semple S, et al
    Rationale and design of the randomized, controlled Early Valve Replacement Guided by Biomarkers of Left Ventricular Decompensation in Asymptomatic Patients with Severe Aortic Stenosis (EVOLVED) trial.
    Am Heart J. 2019;212:91-100.
    PubMed     Abstract available

  114. JENSEN LO, Maeng M, Raungaard B, Engstrom T, et al
    Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomize
    Am Heart J. 2019;213:1-7.
    PubMed     Abstract available

  115. YUDI MB, Clark DJ, Farouque O, Andrianopoulos N, et al
    Trends and predictors of recurrent acute coronary syndrome hospitalizations and unplanned revascularization after index acute myocardial infarction treated with percutaneous coronary intervention.
    Am Heart J. 2019;212:134-143.
    PubMed     Abstract available

  116. LIP GYH, Mauri L, Montalescot G, Ozkor M, et al
    Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial.
    Am Heart J. 2019;212:13-22.
    PubMed     Abstract available

    January 2019
  117. FERRARI R, Ford I, Fox K, Marzilli M, et al
    A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline character
    Am Heart J. 2019;210:98-107.
    PubMed     Abstract available

  118. ISRAELI Z, Lavi S, Pancholy SB, Nombela-Franco L, et al
    Radial versus femoral approach for saphenous vein grafts angiography and interventions.
    Am Heart J. 2019;210:1-8.
    PubMed     Abstract available

  119. KOSMIDOU I, Redfors B, Chen S, Crowley A, et al
    C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial.
    Am Heart J. 2019;210:49-57.
    PubMed     Abstract available

    December 2018
  120. WANG X, Tian M, Zheng Z, Gao H, et al
    Rationale and design of a multicenter randomized trial to compare the graft patency between no-touch vein harvesting technique and conventional approach in coronary artery bypass graft surgery.
    Am Heart J. 2018;210:75-80.
    PubMed     Abstract available

    November 2018
  121. GEENEN LW, Baggen VJM, Koudstaal T, Boomars KA, et al
    The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach.
    Am Heart J. 2018;208:91-99.
    PubMed     Abstract available

    September 2018
  122. GUEDENEY P, Baber U, Claessen B, Aquino M, et al
    Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention: Results from a large single-center prospective registry.
    Am Heart J. 2018;207:10-18.
    PubMed     Abstract available

    August 2018
  123. VAN MIEGHEM NM, Unverdorben M, Valgimigli M, Mehran R, et al
    EdoxabaN Versus standard of care and theIr effectS on clinical outcomes in pAtients havinG undergonE Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.
    Am Heart J. 2018;205:63-69.
    PubMed     Abstract available

  124. MAURI L, Kirtane AJ, Windecker S, Yeh RW, et al
    Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention.
    Am Heart J. 2018;205:110-117.
    PubMed     Abstract available

  125. CHUNG CJ, Kirtane AJ, Zhang Y, Witzenbichler B, et al
    Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents.
    Am Heart J. 2018;205:77-86.
    PubMed     Abstract available

  126. MACK MJ, Abraham WT, Lindenfeld J, Bolling SF, et al
    Cardiovascular Outcomes Assessment of the MitraClip in Patients with Heart Failure and Secondary Mitral Regurgitation: Design and rationale of the COAPT trial.
    Am Heart J. 2018;205:1-11.
    PubMed     Abstract available

    July 2018
  127. FEYZ L, El Faquir N, Lemmert ME, Misier KR, et al
    Prevalence and consequences of noncardiac incidental findings on preprocedural imaging in the workup for transcatheter aortic valve implantation, renal sympathetic denervation, or MitraClip implantation.
    Am Heart J. 2018;204:83-91.
    PubMed     Abstract available

  128. HUGELSHOFER S, Roffi M, Witassek F, Eberli FR, et al
    Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary intervention.
    Am Heart J. 2018;204:34-42.
    PubMed     Abstract available

  129. GIBBONS RJ, Weintraub WS, Brindis RG
    Moving from volume to value for revascularization in stable ischemic heart disease: A review.
    Am Heart J. 2018 Jul 10. pii: S0002-8703(18)30108.
    PubMed     Abstract available

  130. GUALANDRO DM, Puelacher C, LuratiBuse G, Lampart A, et al
    Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery.
    Am Heart J. 2018;203:67-73.
    PubMed     Abstract available

  131. VENETSANOS D, Lawesson SS, James S, Koul S, et al
    Bivalirudin versus heparin with primary percutaneous coronary intervention.
    Am Heart J. 2018;201:9-16.
    PubMed     Abstract available

  132. ZWIJNENBURG RD, Baggen VJM, Geenen LW, Voigt KR, et al
    The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review.
    Am Heart J. 2018;201:63-71.
    PubMed     Abstract available

  133. INOHARA T, Pieper K, Wojdyla DM, Patel MR, et al
    Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.
    Am Heart J. 2018;201:25-32.
    PubMed     Abstract available

  134. RYMER JA, Tempelhof MW, Clare RM, Pieper KS, et al
    Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.
    Am Heart J. 2018;201:103-110.
    PubMed     Abstract available

    June 2018
  135. MYLES PS, Dieleman JM, Forbes A, Heritier S, et al
    Dexamethasone for Cardiac Surgery trial (DECS-II): Rationale and a novel, practice preference-randomized consent design.
    Am Heart J. 2018;204:52-57.
    PubMed     Abstract available

  136. CHI G, Kerneis M, Kalayci A, Liu Y, et al
    Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial.
    Am Heart J. 2018;203:17-24.
    PubMed     Abstract available

  137. LOPES RD, Vora AN, Liaw D, Granger CB, et al
    An open-Label, 2 x 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention:
    Am Heart J. 2018;200:17-23.
    PubMed     Abstract available

  138. CAPLICE NM, DeVoe MC, Choi J, Dahly D, et al
    Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI).
    Am Heart J. 2018;200:110-117.
    PubMed     Abstract available

  139. STEINVIL A, Buchanan KD, Kiramijyan S, Bond E, et al
    Utility of an additive frailty tests index score for mortality risk assessment following transcatheter aortic valve replacement.
    Am Heart J. 2018;200:11-16.
    PubMed     Abstract available

  140. CARSON JL, Stanworth SJ, Alexander JH, Roubinian N, et al
    Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease.
    Am Heart J. 2018;200:96-101.
    PubMed     Abstract available

  141. COLLET JP, Berti S, Cequier A, Van Belle E, et al
    Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial.
    Am Heart J. 2018;200:44-50.
    PubMed     Abstract available

    May 2018
  142. HOLMEN J, Herlitz J, Axelsson C
    Immediate coronary intervention in prehospital cardiac arrest-Aiming to save lives.
    Am Heart J. 2018 May 22. pii: S0002-8703(18)30158.

  143. SHIBATA K, Yamamoto M, Kano S, Koyama Y, et al
    Importance of Geriatric Nutritional Risk Index assessment in patients undergoing transcatheter aortic valve replacement.
    Am Heart J. 2018;202:68-75.
    PubMed     Abstract available

  144. JAKOBSEN L, Christiansen EH, Maeng M, Kristensen SD, et al
    Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian
    Am Heart J. 2018;202:49-53.
    PubMed     Abstract available

  145. WARRAICH HJ, Lu D, Cobb S, Cooper LB, et al
    Trends and outcomes of cardiac transplantation from donors dying of drug intoxication.
    Am Heart J. 2018;199:92-96.
    PubMed     Abstract available

  146. HSU S, Kambhampati S, Sciortino CM, Russell SD, et al
    Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock.
    Am Heart J. 2018;199:181-191.
    PubMed     Abstract available

  147. GHARACHOLOU SM, Ijioma NN, Lennon RJ, Rihal CS, et al
    Characteristics and long term outcomes of patients with acute coronary syndromes due to culprit left main coronary artery disease treated with percutaneous coronary intervention.
    Am Heart J. 2018;199:156-162.
    PubMed     Abstract available

  148. MARWICK TH, Whitmore K, Nicholls SJ, Stanton T, et al
    Rationale and design of a trial to personalize risk assessment in familial coronary artery disease.
    Am Heart J. 2018;199:22-30.
    PubMed     Abstract available

  149. WANG A, Wu A, Wojdyla D, Lopes RD, et al
    Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery.
    Am Heart J. 2018;199:150-155.
    PubMed     Abstract available

    April 2018
  150. O'CONNOR AM, Smith AH, Crum K, Edwards TL, et al
    Analysis of clinical and candidate genetic risk factors for postoperative atrial tachycardia after congenital heart surgery in infants.
    Am Heart J. 2018;202:1-4.
    PubMed     Abstract available

  151. GODOWN J, Smith AH, Thurm C, Hall M, et al
    Mechanical circulatory support costs in children bridged to heart transplantation - analysis of a linked database.
    Am Heart J. 2018;201:77-85.
    PubMed     Abstract available

  152. GALPER BZ, Beery DE, Leighton G, Englander LL, et al
    Comparison of adverse event and device problem rates for transcatheter aortic valve replacement and Mitraclip procedures as reported by the Transcatheter Valve Therapy Registry and the Food and Drug Administration postmarket surveillance data.
    Am Heart J. 2018;198:64-74.
    PubMed     Abstract available

  153. BISHAWI M, Hattler B, Almassi GH, Spertus JA, et al
    Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial.
    Am Heart J. 2018;198:33-38.
    PubMed     Abstract available

  154. KINNAIRD T, Cockburn J, Gallagher S, Choudhury A, et al
    Temporal changes in radial access use, associates and outcomes in patients undergoing PCI using rotational atherectomy between 2007 and 2014: results from the British Cardiovascular Intervention Society national database.
    Am Heart J. 2018;198:46-54.
    PubMed     Abstract available

  155. BERWANGER O, de Barros E Silva PGM, Dall Orto FTC, de Andrade PB, et al
    Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial.
    Am Heart J. 2018;198:129-134.
    PubMed     Abstract available

  156. EGBE A, Khan AR, Al-Otaibi M, Said SM, et al
    Outcomes of hospitalization in adults with Fontan palliation: The Mayo Clinic experience.
    Am Heart J. 2018;198:115-122.
    PubMed     Abstract available

    March 2018
  157. SHAVADIA JS, French W, Hellkamp AS, Thomas L, et al
    Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline program.
    Am Heart J. 2018;197:9-17.
    PubMed     Abstract available

  158. WONG YTA, Kang DY, Lee JB, Rha SW, et al
    Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: A randomized RESTORE trial.
    Am Heart J. 2018;197:35-42.
    PubMed     Abstract available

  159. CZARNY MJ, Miller JM, Naiman DQ, Hwang CW, et al
    Nonprimary PCI at hospitals without cardiac surgery on-site: Consistent outcomes for all?
    Am Heart J. 2018;197:18-26.
    PubMed     Abstract available

  160. REDFORS B, Genereux P, Witzenbichler B, Maehara A, et al
    Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.
    Am Heart J. 2018;197:142-149.
    PubMed     Abstract available

  161. KOPIN D, Jones WS, Sherwood MW, Wojdyla DM, et al
    Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
    Am Heart J. 2018;197:133-141.
    PubMed     Abstract available

  162. HWANG D, Park KW, Lee JM, Rhee TM, et al
    Efficacy and safety of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease.
    Am Heart J. 2018;197:103-112.
    PubMed     Abstract available

  163. FANNING JP, Wesley AJ, Walters DL, Wong AA, et al
    Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation.
    Am Heart J. 2018;197:113-123.
    PubMed     Abstract available

    February 2018
  164. BUCHANAN KD, Rogers T, Alraies MC, Steinvil A, et al
    Temporal trends in patient referral for Transcatheter aortic valve replacement and reasons for exclusion at a high-volume Center in the United States.
    Am Heart J. 2018;196:74-81.
    PubMed     Abstract available

  165. VRANCKX P, Lewalter T, Valgimigli M, Tijssen JG, et al
    Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
    Am Heart J. 2018;196:105-112.
    PubMed     Abstract available

  166. LENG WX, Yang J, Li W, Wang Y, et al
    Rationale and design of the DEAR-OLD trial: Randomized evaluation of routinely Deferred versus EARly invasive strategy in elderly patients of 75 years or OLDer with non-ST-elevation myocardial infarction.
    Am Heart J. 2018;196:65-73.
    PubMed     Abstract available

  167. EGBE A, Khan AR, Miranda WR, Ammash NM, et al
    Mechanism for temporal changes in exercise capacity after Fontan palliation: Role of Doppler echocardiography.
    Am Heart J. 2018;196:144-152.
    PubMed     Abstract available

  168. O'BYRNE ML, Kennedy KF, Rome JJ, Glatz AC, et al
    Variation in practice patterns in device closure of atrial septal defects and patent ductus arteriosus: An analysis of data from the IMproving Pediatric and Adult Congenital Treatment (IMPACT) registry.
    Am Heart J. 2018;196:119-130.
    PubMed     Abstract available

    January 2018
  169. EGBE A, Khan AR, Khan SF, Anavekar NS, et al
    Role of Doppler echocardiography for cardiac output assessment in Fontan patients.
    Am Heart J. 2018;195:91-98.
    PubMed     Abstract available

  170. VEMULAPALLI S, Holmes DR Jr, Dai D, Matsouaka R, et al
    Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
    Am Heart J. 2018;195:1-13.
    PubMed     Abstract available

  171. AFANA M, Gurm HS, Seth M, Frazier KM, et al
    Primary percutaneous coronary intervention at centers with and without on-site surgical support: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Am Heart J. 2018;195:99-107.
    PubMed     Abstract available

  172. LIU E, Hsueh L, Kim H, Vidovich MI, et al
    Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis.
    Am Heart J. 2018;195:39-49.
    PubMed     Abstract available

  173. BANOVIC M, Iung B, Bartunek J, Penicka M, et al
    The Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A protocol update.
    Am Heart J. 2018;195:153-154.

    December 2017
  174. EGBE AC, Huntley GD, Connolly HM, Ammash NM, et al
    Outcomes of cardiac pacing in adult patients after a Fontan operation.
    Am Heart J. 2017;194:92-98.
    PubMed     Abstract available

  175. GODOWN J, Thurm C, Dodd DA, Soslow JH, et al
    A unique linkage of administrative and clinical registry databases to expand analytic possibilities in pediatric heart transplantation research.
    Am Heart J. 2017;194:9-15.
    PubMed     Abstract available

  176. BARON SJ, Arnold SV, Reynolds MR, Wang K, et al
    Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
    Am Heart J. 2017;194:39-48.
    PubMed     Abstract available

  177. LEE S, Kang DH, Kim DH, Song JM, et al
    Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.
    Am Heart J. 2017;194:1-8.
    PubMed     Abstract available

  178. QADERDAN K, Vos GA, McAndrew T, Steg PG, et al
    Outcomes in elderly and young patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with bivalirudin versus heparin: Pooled analysis from the EUROMAX and HORIZONS-AMI trials.
    Am Heart J. 2017;194:73-82.
    PubMed     Abstract available

  179. INOHARA T, Numasawa Y, Higashi T, Ueda I, et al
    Predictors of high cost after percutaneous coronary intervention: A review from Japanese multicenter registry overviewing the influence of procedural complications.
    Am Heart J. 2017;194:61-72.
    PubMed     Abstract available

    November 2017
  180. DOROS G, Massaro JM, Kandzari DE, Waksman R, et al
    Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach.
    Am Heart J. 2017;193:35-45.
    PubMed     Abstract available

  181. LEE PH, Lee JY, Lee CW, Han S, et al
    Long-term outcomes of bypass grafting versus drug-eluting stenting for left main coronary artery disease: Results from the IRIS-MAIN registry.
    Am Heart J. 2017;193:76-83.
    PubMed     Abstract available

  182. MUSTO C, De Felice F, Rigattieri S, Chin D, et al
    Instantaneous wave-free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST-segment elevation myocardial infarction: The WAVE study.
    Am Heart J. 2017;193:63-69.
    PubMed     Abstract available

    October 2017
  183. MOJOLI M, Gersh BJ, Barioli A, Masiero G, et al
    Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Am Heart J. 2017;192:64-75.
    PubMed     Abstract available

  184. KESSLER M, Gonska B, Seeger J, Rottbauer W, et al
    Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Am Heart J. 2017;192:57-63.
    PubMed     Abstract available

    September 2017
  185. GUDNADOTTIR GS, Andersen K, Thrainsdottir IS, James SK, et al
    Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes.
    Am Heart J. 2017;191:65-74.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.